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Abstract
Autosomal dominant limb girdle muscular dystrophy D3 HNRNPDL-related is a rare dominant myopathy caused by muta-
tions in HNRNPDL. Only three unrelated families have been described worldwide, a Brazilian and a Chinese carrying the 
mutation c.1132G>A p.(Asp378Asn), and one Uruguayan with the mutation c.1132G>C p. (Asp378His), both mutations 
occurring in the same codon. The present study enlarges the clinical, morphological and muscle MRI spectrum of AD-
HNRNPDL-related myopathies demonstrating the significant particularities of the disease. We describe two new unrelated 
Argentinean families, carrying the previously reported c.1132G>C p.(Asp378His) HNRNPDL mutation. There was a wide 
phenotypic spectrum including oligo-symptomatic cases, pure limb girdle muscle involvement or distal lower limb muscle 
weakness. Scapular winging was the most common finding, observed in all patients. Muscle MRIs of the thigh, at different 
stages of the disease, showed particular involvement of adductor magnus and vastus besides a constant preservation of the 
rectus femoris and the adductor longus muscles, defining a novel MRI pattern. Muscle biopsy findings were characterized 
by the presence of numerous rimmed vacuoles, cytoplasmic bodies, and abundant autophagic material at the histochemistry 
and ultrastructural levels. HNRNPDL-related LGMD D3 results in a wide range of clinical phenotypes from the classic 
proximal form of LGMD to a more distal phenotype. Thigh MRI suggests a specific pattern. Codon 378 of HNRNPDL gene 
can be considered a mutation hotspot for HNRNPDL-related myopathy. Pathologically, the disease can be classified among 
the autophagic rimmed vacuolar myopathies as with the other multisystem proteinopathies.
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Introduction
According to the recent definition established by a group 
of experts at the 229th European Neuromuscular Centre 
(ENMC)international workshop in 2017: ‘Limb girdle 
muscular dystrophy (LGMD) is a genetically inherited 
condition that primarily affects skeletal muscle leading to 
progressive, predominantly proximal muscle weakness at 
presentation’ [1]. Among LGMD, the autosomal dominant 
forms are relatively rare and represent 10% of all LGMD 
[2]. According to the new LGMD classification, autosomal 
dominant LGMD includes: LGMDD1 DNAJB6-related, 
LGMDD2 TNPO3-related, LGMDD3 HNRNPDL-related 
and LGMDD4 CAPN3-related myopathy [1].
LGMDD3 HNRNPDL-related, previously LGMD1G 
(OMIM #609115) was first described in 2004 in a domi-
nant Brazilian-Caucasian family with 12 patients distrib-
uted over three generations [2]. The age at onset varied 
from 30 to 47 years. The slowly progressive disease started 
with proximal lower limbs involvement later followed by 
proximal upper limbs weakness. Progressive finger and 
toe flexion limitations and muscle cramps were present 
in most patients. Serum creatinekinase (CK) activity was 
normal or slightly increased. Muscle histology was avail-
able for one patient and described as a “myopathic pat-
tern” with fibre size variability, necrotic fibres, groups 
of atrophic angulated fibres, and rimmed vacuoles [2]. In 
2014, LGMDD3HNRNPDL-related was also reported in 
a Uruguayan family with 18 affected members [3].The age 
of onset varied from 15 to 55 years of age. The clinical 
signs were similar to those of the Brazilian family, but in 
8 patients the symptoms started with proximal upper limb 
weakness and difficulty to raise the arms. Additionally, 
some affected members presented early onset cataracts 
[3].For both the Brazilian and Uruguayan families; the 
disease affected both sexes with incomplete penetrance. 
Genome sequencing identified two different missense 
mutations in HNRNPDL (on chromosome 4q21) encod-
ing the heterogeneous nuclear ribonucleoprotein D-like 
(hnRNPDL). Both mutations were heterozygous and 
affected the same aminoacid: p.(Asp378Asn) in the Bra-
zilian family and p.(Asp378His) in the Uruguayan family. 
Recently, a Chinese family with 10 affected individuals 
over three generations was reported to carry the origi-
nal Brazilian p.(Asp378Asn) mutation [4].While muscle 
morphology showed similar features with the presence of 
rimmed vacuoles, the clinical phenotype slightly differed 
from the previously reported families with half of the Chi-
nese patient’s presenting distal as well as proximal limb 
weakness. Flexion limitation of fingers and toes, which 
was a typical feature in the other two reported families, 
was not present, highlighting the broad clinical spectrum 
of the disease.
hnRNPDL acts as a regulator of pre-mRNA splicing 
and nuclear export. HNRNPDL mutations are thought to 
cause defects in mRNA biogenesis and metabolism [5].This 
DNA/RNA-binding protein has been shown to localize in 
the cytoplasm and in the nucleus [6, 7]. Data from Vieira 
et al. 2014, suggested that the translocation of the protein 
from the cytoplasm to the nucleus might be impaired by 
the p.(Asp378Asn)mutation. This could prevent the pro-
tein to access to the nucleus to perform its function on pre-
mRNA maturation. Many hnRNPs were linked to various 
diseases due to their crucial role in the regulation of gene 
expression [8]. Mutations in the prion-like domains (PrLD) 
of hnRNPA1 and hnRNPA2B1 cause a multisystem pro-
teinopathy (MSP), an inherited pleiotropic degenerative dis-
order that can affect muscle, bone, and the nervous system. 
However, an isolated myopathy has also been described in 
association with hnRNPA1 mutations [9]. Affected tissues in 
multisystem proteinopathies present ubiquitin-positive inclu-
sions that contain RNA-binding proteins, such as hnRNPA1 
and hnRNPA2B1, and may stain positive for proteins that 
mediate ubiquitin-dependent autophagy [9]. Rimmed vacu-
olation is a key feature of the myopathology in MSP [10].
Here we describe two unrelated families from Argentina 
with LGMDD3 HNRNPDL-related at the clinical, muscle 
imaging, histopathological and ultrastructural level.
Materials and methods
Patients
Two unrelated Argentinean families of European ancestry 
with history of adult-onset myopathy were included in the 
study (Fig. 1: family A and family B). All patients under-
went detailed clinical examination summarized in Table1.
Morphological studies
Open muscle biopsies of the quadriceps were obtained from 
four patients, three (III-1, II-6 and II-9) from family A (FA) 
and one (III-1) from family B (FB) (Fig. 1). For conventional 
histochemical techniques 10-μm thick cryostat sections were 
stained with haematoxylin and eosin (HE), modified Gomori 
trichrome (mGT), Periodic-acid Schiff technique (PAS), Oil 
red O, nonspecific esterase, reduced nicotinamide adenine 
dinucleotide dehydrogenase-tetrazolium-reductase(NADH-
TR), succinic dehydrogenase (SDH), cytochrome c oxidase 
(COX), menadione-nitro blue tetrazolium and adenosine 
triphosphatase (ATPase) pre-incubated at pH 9.4, 4.63, 4.35.
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Immunohistochemistry (IHC)
IHC was performed in frozen muscle sections from patients 
III-1, II-6, II-9from FA. Antibodies against Desmin (Anti-
Human Desmin, Clone D33, Dako Laboratories, Denmark 
A/S), Myotilin (NCL-Myotilin, Novocastra Laboratories, 
Newcastle Upon Tyne, United Kingdom), αB-crystallin 
(CRYAB, GeneTex International Corporation, Irvine, USA), 
C5b9 (Dako), P62 (BD-Transduction Laboratories) and anti-
bodies against dystrophin (Dys2, Leica), a, b, g, d sarcogly-
cans (Leica), alpha 2 laminin, dysferlin (Leica), were applied 
to 10 µm thick cryosections and revealed using immunop-
eroxidase techniques.
Electron microscopy
Electron microscopy (EM) was performed in three cases 
(FA.III-1,FA.II-6 and FB.III-1).Small muscle samples 
were fixed in 2.5% glutaraldehyde, pH 7.4, post-fixed 
in 4% osmium tetroxide, dehydrated and embedded in 
araldite. Several blocks from each patient were studied, 
including longitudinally and transversally oriented sam-
ples. Semi-thin sections were stained with toluidine-blue 
and examined on light microscopy. Ultrathin sections were 
stained with uranyl acetate and lead citrate (Reynolds) and 
viewed with a Zeiss EM 109 T.
Fig. 1  Family A and Family B pedigrees
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Genetic analysis
In family A (Fig. 1), exome sequencing was performed for 
individuals FA.II-6, FA.II-7 and FA.II-9 with the SureSe-
lect Human All Exon 50 Mb capture library v5 (Agilent, 
Santa Clara, USA). Samples were paired-end sequenced on 
Illumina HiSeq 2500 (Illumina, San Diego, USA). In family 
B (Fig. 1), exome sequencing was performed on the index 
patient (FB.III-1) with Roche SeqCap EZ Human Exome 
v3 with 75 bp paired end reads and sequenced on Illumina 
NextSeq 550 (Illumina, San Diego, USA).
Alignment was performed on the GRCh37/hg19 reference 
genome and the variants were filtered using their frequency 
in gnomAD (https ://gnoma d.broad insti tute.org/) and in our 
in-house database containing over 1500 exomes. The vari-
ants with minor allele frequency over 0.01 were removed 
from analysis. The mutation was numbered according to the 
GenBank NM_031372.3 with +1 corresponding to the A of 
the ATG translation initiation codon.
In family A, confirmation of variants and segregation was 
performed with Sanger sequencing for four affected (FA.
II-6, FA.II-9, FA.II-10, FA.III-1) and three healthy individu-
als (FA.II-5, FA.II-7, FA.III-2). In family B, the segrega-
tion was verified by Sanger sequencing in three other family 
members (FB.II-1, FB.II-2 and FB.III-2).
Magnetic resonance imaging (MRI)
Muscle MRI was performed in one member from family A 
(FA.II-6) and two from family B (FB.III-1, FB.II-1). Fast 
Spin Echo (FSE) T1 and T2-weighted STIR (Short-tau 
inversion recovery) images were acquired in axial and coro-
nal planes of both thighs and legs. We analysed and classi-
fied all cases considering the type of involvement of each 
muscle: perifascial, concentric, mottled, muscle atrophy vs. 
hypertrophy, oedema vs. fatty infiltration, the muscles most 
affected in each compartment, using the Mercuri score [11, 
12].
Results
Phenotypic presentation and clinical investigations
Family A (FA)
An Argentinean family originally from the province of 
Buenos Aires with Italian ancestry. There were 10 affected 
family members over 3 generations (Fig. 1). All affected 
individuals had a normal early motor development. The age 
at onset ranged from 38 to 48 years. The initial symptoms 
were proximal lower limb weakness in two patients (FA.II-6, 
II-9) associated with distal lower limb weakness in one of 
them (FA.III-1). Scapular winging and anterior thigh atro-
phy were common findings in all patients (Fig. 2). Other 
symptoms and signs were muscle cramps (FA. I-6, II-6 and 
II-10) and early onset cataracts (FA. I6, II-4, II-6 and II-10). 
No additional clinical information was available from the 
deceased relatives.
FA.III‑1
A 56-year-old male with asymmetric distal lower limb weak-
ness from the age of 38, unable to walk on heels. Muscle 
weakness progressed to the proximal lower limb muscles, 
and to the shoulder and arm muscles. This resulted in fre-
quent falls. Later on, he developed limitations of finger and 
toe flexors. At present he is unable to raise his arms, has 
marked bilateral scapular winging (Fig. 2b), symmetrical 
quadriceps atrophy and walks with a cane. No cataracts were 
observed. CK levels were variably increased at several deter-
minations, with values between 677-1800 IU/l [normal val-
ues (nv): 55–170 IU/l]. Cardiovascular and pulmonary eval-
uation was unremarkable. He had two non-affected brothers 
that are deceased. His deceased father developed scapular 
winging during adulthood and cataracts at 70 years of age.
FA.II‑6
A 68-year-old woman whose first symptom was early onset 
cataracts revealed at the age of 42 years. By the age of 48, 
she developed proximal lower limb weakness, progressive 
difficulty in climbing stairs and frequent falls. Later on, 
the weakness progressed to distal muscles with movement 
limitation affecting first the toes and later the finger flexors 
and small hand muscles. Scapular winging was also present 
(Fig. 2e).Currently she has both proximal and distal lower 
limb weakness (MRC 3/5), walks with a cane, and experi-
ences frequent cramps in her feet, legs, and hands. She had a 
medical history of hypothyroidism controlled with medica-
tion. The CK levels were slightly elevated at 300 IU/l (nv: 
30–135 IU/l). The EMG showed a “myopathic” pattern con-
sistent with a distal involvement with normal nerve conduc-
tion studies (NCS).
FA. II‑9
A 59-year-old man, started at the age of 38 with proximal 
and later on distal muscle weakness. Similar to the other 
patients he presented with limitation of toes and later finger 
flexors; and scapular winging (Fig. 2a). He has a normal 
cardiovascular evaluation; reduced forced vital capacity with 
ventilatory insufficiency.
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Family B (FB)
An Argentinean family from the province of Entre Rios, with 
French-Basque ancestry with 5 affected members over three 
generations (Fig. 1). Age at onset varied from 41 to 63-year-
old with progressive proximal lower limb muscle weakness. 
There was no history of early onset cataracts or restriction 
of finger and toe flexion with reduced range of movement in 
the interphalangeal joints.
FB.III‑1
A 46-year-old man, semi-professional cyclist, started to 
experience progressive weakness and wasting of the quadri-
ceps from the age of 41. He has difficulty standing from 
the crouched position, has occasional unexplained falls and 
some difficulty climbing stairs. Cardiopulmonary examina-
tion was normal. The maternal grandfather and three great 
uncles were affected by a similar, late onset, muscle condi-
tion. At the time of his first examination at age 41, he had 
no shoulder girdle or upper arm muscles weakness but a 
mild bilateral scapular winging; prominent atrophy of the 
vastus lateralis and medialis and a striking preservation of 
the rectus femoris (knee extension: MRC power grade 4-/5) 
(Fig. 2d,g). Atrophy of the posterior thigh compartment was 
noticed as well as abdominal weakness. Pelvic girdle weak-
ness was present with hip adduction and abduction being 
compromised (MRC power grade 4+/5). Muscle strength 
was preserved in the lower legs and there was calf hypertro-
phy. Five years after the first evaluation a more pronounced 
scapular winging (Fig. 2c) and shoulder weakness with no 
lower limb distal weakness was observed. No finger or toes 
flexion limitation was present. The CK levels were mildly 
elevated (862 U/l; nv: 55–170 UI/l) and the electromyogra-
phy was consistent with a “myopathic” pattern.
FB.II‑1 case
The mother of the proband, a 65-year-old woman, showed a 
slight weakness of the vastus muscles (Knee extension MRC 
4+/5), mild and asymmetrical scapula displacement (Fig. 2f) 
and lumbar scoliosis. The patient reports occasional lower 
limb cramps and for the last 3 years some difficulties climb-
ing stairs. The CK level was normal. There is no history of 
early onset cataracts.
Muscle biopsies
Histochemistry
Quadriceps muscle biopsies from patients FA.III-1, FA.II-
6, FA.II-9, FB.III-1 at the age of 42, 55, 40 and 41 years-
old, respectively, showed the presence of rimmed vacuoles, 
autophagic vacuoles and cytoplasmic bodies (Fig. 3). There 
Fig. 2  Scapular winging and vastus atrophy are common clinical 
findings. Scapular winging was a common finding in patients: FA.II-9 
(a), FA.III-1 (b), FB.III-1 (c), FA.II-6 (e) andFB.II-1 (f). Severe thigh 
atrophy was present in all patients (patient B.III-1) (d, g). In case 
B.II-1 (f) although she carries the mutation, slight symptoms were 
present. Marked atrophy of vastus muscles were observed with pres-
ervation of the rectus femoris (Patient B.III-1) (g)
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was variability in muscle fibre size with the presence of 
atrophic fibres and a few pyknotic nuclear clumps. There 
was a moderate increase in the endomysial/perimysial con-
nective tissue and in one case, some necrotic/regenerating 
fibres were observed.
Immunohistochemistry (IHC)
Dystrophin; lamininalpha-2; alpha, beta, gamma, and delta 
sarcoglycans labelling was preserved. ForFA.II-9: Some of 
the vacuoles were labelled with antibodies for dystrophin, 
thus confirming the presence of sarcolemma membranes in 
the vacuoles as previously described. IHC study for desmin, 
myotilin, and αB-crystallin did not show any specificity, 
with only an inconsistent and unspecific immunostaining 
of a few degenerating fibres. Some vacuoles were labelled 
with the antibodies against C5b9 and dystrophin and a good 
number of muscle fibres presented accumulations of P62.
Ultrastructural study
Electron microscopy studies were performed in three muscle 
biopsies (FA.III-1,FA.II-6 and FB.III-1) (Fig. 4). All biop-
sies showed marked autophagic changes, particularly in 
patients FA.III-1 and FB.III-1 and less prominent in patient 
FA.II-6. We could observe numerous vacuoles containing 
membranous remnants, myeloid bodies, and cytoplasmic 
bodies (Fig. 4b, c, f). The myofibrils were regularly dis-
sociated by amorphous material from the autophagy debris. 
Cytoplasmic areas with tubulofilamentous inclusions, a 
structural marker of rimmed vacuoles, were detected in some 
muscle fibres (Fig. 4a, d). Additionally, remaining segments 
of disrupted sarcomeres were present in the disorganized 
regions of the fibres, and small areas of dispersed filamen-
tous bundles of Z-disc origin were also noted (Fig. 4e). 
Of note that, neither granular filamentous aggregates nor 
nuclear tubulofilamentous inclusions were observed in these 
muscle biopsies.
Genetic analysis
By exome sequencing, we identified the same heterozygous 
HNRNPDL mutation in both families. This missense muta-
tion, c.1132G>C p.(Asp378His), affects a conserved amino 
acid encoded by exon 6 of HNRNPDL. The mutation was 
not listed in gnomADor in our in-house database contain-
ing over 1500 exomes and was previously reported as caus-
ing LGMDD3. In family A, the presence of the HNRNPDL 
mutation in the patients and its absence in the healthy fam-
ily members was confirmed by Sanger sequencing. In F.B, 
HNRNPDL: c.1132G>C p.(Asp378His) was found in the 
index patient as well as the mother, whereas the father and 
the healthy brother did not harbour the mutated allele.
MRI findings
MRI findings showed in the three cases analysed at the 
thighs, a selective pattern involving heavily adductor mag-
nus and vastus muscles with preservation of rectus femoris 
and adductor longus (Fig. 5). Lower distal leg involvement 
Fig. 3  Histochemistry. Frozen muscle sections from patients: FA. 
III-1 (a–c) and FB. III-1 (d–f). Marked variability of fibre size with 
some atrophic fibres. Numerous rimmed vacuoles and abundant 
autophagy lesions were observed in many fibres: a (HE), b (GT), d 
(HE) and e (GT). Vacuoles and some areas of disorganized structure 
were also detected with oxidative techniques: c and f (NADH-TR)
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was present only in one patient showing replacement of ante-
rior compartment and soleus muscles.
FA. II‑6
Muscle MRI shows a diffuse, symmetric, fatty infiltration 
of the gluteus minimus and ilio-psoas muscles; moderate 
fatty infiltration of the gluteus maximus predominantly on 
the right and of the tensor fascia lata with relative sparing 
of gluteus medium muscles. At the thighs, on the anterior 
compartment, a selective involvement of vastus medialis, 
intermedius and lateralis, sartorius, adductor magnus, with 
relative sparing of the rectus femoris and adductor longus 
muscles were observed (Fig. 5e). On the posterior compart-
ment there was a severe involvement of the semitendinosus 
with relative sparing of the semimembranosus and long head 
of biceps femoris. At the lower legs the tibial anterior, exten-
sor hallucis and soleus were affected (Fig. 5f).
FB.III‑1
Thigh MRI showed severe fatty infiltration of all vastus mus-
cles, sartorius and adductor magnus with relative sparing of 
gracilis, biceps femoris, semitendinosus, and semimembra-
nosus muscles. Preservation of rectus femoris and adductor 
longus were observed with hypertrophy of rectus femoris 
(Fig. 5c). At the lower leg there was no evident muscle 
involvement (Fig. 5d).
FB. II‑1
Severe fatty infiltration was observed in the vastus lateralis, 
adductor magnus and sartorius muscles with relative sparing 
of rectus femoris and the adductor longus (Fig. 5a). Semiten-
dinosus, semimembranosus and biceps femoris were moder-
ately affected. At the lower leg level, no evident involvement 
was detected (Fig. 5b).
Comparative MRI studies
Comparative MRI studies from both FA. II-6 and FB.III-1 
patients were performed with an interval of 12 years and 
4 years, respectively (Fig. 6).
Discussion
LGMDD3 HNRNPL-related is caused by heterozygous 
mutations in the HNRNPDL gene. Until now, only three 
families were described worldwide: a Brazilian-Caucasian, 
a Uruguayan, and a Chinese family [2-4]. The missense 
mutations in HNRNPDL affected the same aminoacid in all 
families although the transition is different: p.(Asp378Asn) 
in the Brazilian and Chinese families and p.(Asp378His) in 
the Uruguayan family. The description of several families 
carrying the mutation in the same amino acid could define 
a mutational hotspot.
This study describes two unrelated Argentinian fami-
lies with European ancestry (Italian/French-Basque) with 
Fig. 4  Ultrastructural findings. Longitudinal muscle sections from 
patients: FA. III-1 (a–c) and FB. III-1 (d–f). The autophagic vacuoles 
containing membranous remnants, myeloid bodies and some glyco-
gen granules (b, f) are observed among the myofibrils. Cytoplasmic 
bodies (c) and few zones with spread filamentous bundles of Z-disc 
material (e) were also noted. Areas with tubulofilamentous inclu-
sions, a structural marker of rimmed vacuoles, were detected in some 
muscle fibres (a, d)
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LGMDD3 HNRNPDL-related, histologically characterized 
by marked autophagy with numerous rimmed vacuoles asso-
ciated with the p.(Asp378His) dominant HNRNPDL muta-
tion. Moreover, we provide new clinical, histopathology and 
ultrastructural findings, as well as evidence of a selective 
muscle MRI involvement which seems to be specific in any 
stages of the disease, even in oligo-symptomatic patients.
In our two families, the disease manifested with two 
different initial phenotypes; a typical late onset limb gir-
dle proximal weakness with atrophy of the thighs, and a 
distal asymmetric lower limb ankle dorsiflexion weakness. 
Whereas limitation of fingers flexors was a late manifestation 
in all members of one of our families, early onset cataracts 
were present in only four patients. Despite the variable pres-
entation in both families, scapular winging was a regular 
clinical finding in all affected patients. The presence of a 
65 years-old oligo-symptomatic patient reinforces previous 
descriptions regarding variable clinical severity of the dis-
ease. In our cohort, as in previous reported series, the myo-
pathy usually manifested as a late onset slowly progressive 
disorder, the age of onset ranging from 38 to 63 years. Nor-
mal cardiac and respiratory assessments in most of the stud-
ied patients could suggest that cardiac and respiratory insuf-
ficiency may not be a feature of this condition, however, the 
oldest patient in this series presents a reduction of the FVC 
over time with a pattern that may suggest the diaphragm 
is compromised. We, therefore, suggest that the respira-
tory function should be monitored in this condition. Some 
clinical similarities can be established between LGMD D3 
HNRNPDL-related and myopathies associated with muta-
tions in other genes coding for other heterogeneous nuclear 
ribonucleoproteins (hnRNPs) such as hnRNPA1. Rimmed 
vacuolar myopathy has been documented with mutations in 
hnRNPA1, causing a similar autosomal dominant, late onset 
Fig. 5  MRI reveals a specific muscle pattern at the thigh. T1 
weighted MRI sections shows preservation of adductor longus and 
rectus femoris as a common finding in all patients, even in differ-
ent stages of the disease. a Thigh MRI Patient FB.II-1 performed at 
age 68; severe fatty infiltration was observed on the vastus lateralis, 
adductor magnus and sartorius muscles with relative sparing of rec-
tus femoris (arrow) and the adductor longus (arrow). Semitendinosus, 
semimembranosus and biceps femoris were moderately affected. b At 
the leg level no evident involvement was observed. c Thigh MRI in 
patient FB.III-1 performed at age 46 showed severe fatty infiltration 
of vasti muscles, Sartorius and adductor magnus with relative spar-
ing of gracilis, biceps femoris, semitendinosus and semimembrano-
sus muscles. Preservation of rectus femoris and adductor longus were 
observed with hypertrophy of rectus femoris. d At the leg level no 
evident involvement was observed. e Muscle MRI in patient FA.II-6 
performed at 68-year-old. At the thigh level, almost complete fatty 
replacement is observed with selective involvement of vastus media-
lis, intermedius and lateralis, sartorius and adductor magnus with 
relative sparing of the rectus femoris and adductor longus. In the pos-
terior compartment, severe involvement of semitendinosus was seen, 
with relative sparing of semimembranosus and long head of biceps 
femoris. f At the legs, tibial anterior (arrow), extensor hallucis and 
soleus (arrow) were also affected
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myopathy with distal or proximal lower limb onset and no 
cardiac or respiratory involvement [9, 10, 13].
Our MRI findings allow us to postulate a specific and 
pathognomonic pattern of involvement of the thighs with 
preservation of the rectus femoris and adductor longus, 
even at late stages of the disease (Figs. 5, 6).These find-
ings are in accordance with the previous description by 
Sun et al. (2019), showing a strikingly similar muscle MRI 
pattern. Vastus muscles seem to be early and particularly 
affected and probably may correlate with the early falls of 
the patients. In contrast, no leg-specific muscle involvement 
was observed. A similar muscle MRI pattern, with preserva-
tion of the rectus femoris was described previously in MSPs 
like hnRNPA1 and hnRNPA2B1 associated diseases [9]. The 
reason for the selective involvement of some particular mus-
cles with relatively sparing of others remains unclear. We 
could speculate that a possible association of myotoxicity 
with the levels of mutant HRNPNDL in different muscles 
might be related with the selective muscle involvement, or 
some muscles being more dependent on correct mRNA-
processing than others. Selective muscle involvement is not 
a specific finding of LGMD D3 HNRNPDL-related, but 
rather a common finding in muscular dystrophies. Previous 
reports demonstrated significant variations in isoform and 
gene expression levels in anatomically different muscles as 
one of the possible explanations of this discrepancy [14]. 
Other factors remain to be clarified.
The muscle biopsy studies allowed us to demonstrate 
a particular morphological pattern characterized by fibres 
harbouring numerous autophagic rimmed vacuoles and 
cytoplasmic bodies. Electron microscopy, performed for the 
first time in HNRNPDL-related LGMD D3, demonstrated 
autophagic changes with numerous vacuoles containing 
membranous remnants, myeloid bodies, besides cytoplas-
mic bodies and some filamentous material. Myofibrils in 
dissolution were separated by amorphous autophagic debris 
material (Fig. 4).
The morphological and clinical aspects of the HNRN-
PDL-related myopathy, suggest that this entity should be 
included in the group of the “autophagic vacuolar myopa-
thies” (AVM) instead of the LGMD. Of note, the cases pre-
viously reported of HNRNPDL-related muscular dystrophy 
in the literature did not include electron microscopy studies 
and the morphological description was very limited. These 
facts have led to the classification of this entity as an autoso-
mal dominant muscular dystrophy mostly based on the clini-
cal phenotype. With the new findings in electron microscopy 
that we report here, we postulate that the histological phe-
notype is compatible with an AVM and we suggest that the 
classification of this entity should be reconsidered.
Fig. 6  Comparative thigh MRI in two different patients. T1 weighted 
comparative thigh MRI performed in patient FA.II-6 (56-year-old 
and 68-year-old) (a, b) and FB.III-1 (42-year-old and 46-year-old) 
(c, d) which illustrates selective sparing of rectus femoris (asterisk) 
and adductor longus (asterisk) through the years with marked degen-
eration of vasti. Posterior compartment muscles in case FA.II-6 were 
severely affected with the exception of semimembranosus and biceps 
femoris whereas in FB.III-2 are less affected
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HNRNPDL belongs to the subfamily of the heterogene-
ous nuclear ribonucleoproteins (hnRNPs) essential for the 
maturation of newly formed heterogeneous nuclear pre-
mRNA into mRNA and the transport of mRNA. They are 
key proteins in the RNA metabolism and many hnRNP genes 
are known to cause degenerative diseases in particular with 
mutations in the prion-like domains (PrLD). Mutations in 
the PrLD of hnRNPA1 and A2B1 cause MSP [10]. Muta-
tions in the PrLD of TIA1 cause rimmed vacuolar distal 
myopathies [15]. Mutations in the PrLD increase the ten-
dency to self-aggregation.
In conclusion, HNRNPDL-related LGMD D3 results in 
a wide range of phenotypes from the classic proximal form 
of LGMD to a more distal phenotype. Codon 378 of HNRN-
PDL gene can be considered a mutation hotspot for HNRN-
PDL-related myopathy. Moreover, cataracts and limited 
fingers flexion may not be uniform findings. On the other 
hand, scapular winging is an important clinical key sign with 
similarity to VCP mutated MSP myopathy. The preservation 
of rectus femoris and adductor longus muscles is a com-
mon MRI feature at all stages of the disease. Pathologically 
the disease can be classified among the autophagic rimmed 
vacuolar myopathies as with the other MSP myopathies.
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